A casual observer of Wednesday’s House Energy and Commerce subcommittee hearing might think insulin prices just go up by themselves. After all, the key industry executives filed opening statements to the congressional panel outlining patient-assistance programs, coupons and discounts — a range of price reductions that might make one think this life-or-death diabetes medication is easily affordable to the patients who need it. In fact, the price of insulin nearly doubled from 2012 to 2016 alone, triggering national headlines about the resulting hardships — sometimes deadly — suffered by people with the Type I-version of the condition who are left to ration insulin because it is too expensive for them to use as prescribed. Don't Miss A Story Subscribe to KHN’s free Weekly
From https://khn.org/news/the-blame-game-everyone-and-no-one-is-raising-insulin-prices/
from
https://healthnews010.wordpress.com/2019/04/11/the-blame-game-everyone-and-no-one-is-raising-insulin-prices/
No comments:
Post a Comment